Journal Of Clinical Oncology (jco) Podcast
Can We Simplify the Treatment of Myelofibrosis?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:51
- More information
Informações:
Synopsis
In this randomized trial, momelotinib was non-inferior to ruxolitinib for spleen response but was less effective in controlling symptoms. Related Article: SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
